New pill targets Hard-to-Treat cancers in early human trial
Disease control
Recruiting now
This early-phase study is testing a new oral drug called PEP08 in up to 40 adults with advanced or metastatic solid tumors that have lost a gene called MTAP. The drug works by blocking a protein that cancer cells need to grow. The main goals are to check safety, find the right do…
Phase: PHASE1 • Sponsor: PharmaEngine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC